#Hematology Brentuximab vedotin and chemotherapy in relapsed/refractory #Hodgkin #lymphoma: a propensity score–matched analysis | ⁦Blood Advances⁩ | American Society of Hematology ⁦ASH⁩ #lymsm ashpublications.org/bloodadvances/…

#Hematology Outcomes of subsequent anti#lymphoma therapies after second-line axicabtagene ciloleucel or standard of care in ZUMA-7 | ⁦Blood Advances⁩ | American Society of Hematology ⁦ASH⁩ #CARTcell #lymsm ashpublications.org/bloodadvances/…

Lymphoma Coalition is the proud recipient of the Diversity, Equity, and Inclusion (DEI) Award by the European Hematology Association (EHA) which has just been presented during the congress in Madrid, Spain. This accolade is the first of its kind and underscores the steadfast commitment to

Lymphoma Coalition is delighted to announce that John Gribben, respected Member of LC’s Board of Medical Directors, has been awarded the prestigious José Carreras Award at the EHA Congress in Madrid, Spain. The José Carreras Award was established to honor leaders in

GLPG5101 anti-CD19 CAR-T product reduces manufacturing time from vein-to-veint to 7 DAYS!! ⌚️ Time is important in R/R NHL patients receiving CAR-T... Presented by MarieJosé Kersten at #EHA2024 [S243]

"Images are more than pictures, they are data" Great talk about radiomics in DLBCL! European Hematology Association #lymphoma Group MarieJosé Kersten #EHA2024

Lymphoma Working Party Educational Course 2024. Join us in #Rotterdam Great outline of speakers and opportunity to network! ⁦The EBMT Trainee Committee⁩ ⁦YoungEHA⁩ ⁦The EBMT⁩ ⁦Erasmus MC Hematology⁩ ebmt.org/events/lymphom…

Today is World Sickle Cell Day. The global burden for this disease is enormous and more research is needed! Today Aafke Gaartman successfully defended her thesis on advances in supportive care and novel Treatments. Congratulations! Amsterdam UMC Sanquin

📣 #ESHLYMPHOMA2024 PROGRAMME HIGHLIGHT: Debate 2! To attend it, register here ➡ bit.ly/3NDQ8Lq 4th How to Diagnose and Treat #LYMPHOMA 🗓️ November 1-3, 2024 - Stockholm 🇸🇪 Chairs: Christian Buske, Michael Crump, Gilles Salles, C. Thieblemont #ESHCONFERENCES #Lymsm

If you find your PhD topic at your IKIGAI, you've already won.

Fresh off the press, exciting results from Frank et al Stanford Medicine CD22-directed CAR T-cell therapy for large B-cell lymphomas progressing after CD19-directed CAR T-cell therapy: a dose-finding phase 1 study thelancet.com/journals/lance… Looking forward to the multicenter phase 2

Congrats to the now Dr. Ruchi Patel for the publication of her PhD thesis in Science Immunology. We show here that CD5 deletion enhances CART immunotherapy in multiple solid and liquid cancer models. Penn Medicine Ruella Lab science.org/doi/10.1126/sc…

Blijft goed.

For medics interested in a PhD in cancer research - we have a CAR-T project available at UCL please get in touch if interested.

🟣 Are you represented on Women In Lymphoma - [email protected] 's global membership map? 🌏If not, please join 1,200+ WiL members for free educational webinars & networking by emailing [email protected] 👉please share/retweet #lymphoma #lymsm

Axicabtagene ciloleucel vs standard of care in second-line large B-cell lymphoma: outcomes by metabolic tumor volume ashpublications.org/blood/article-…

Aaron Goodman - “Papa Heme” Would be nice if trials like POLARIX allowed for patients with HIV if they are well controlled on HAART with good CD4 counts….

Landmark Paper: Combination chemotherapy for Hodgkin lymphoma AUTHORS Devita VT Jr, Serpick AA, Carbone PP. JOURNAL Annals of Internal Medicine 1970;73(6):881-895. doi: 10.7326/0003-4819-73-6-881 Haematologica Alison Moskowitz doi.org/10.3324/haemat… haematologica.org/article/view/1…

📢 New European Hematology Association (EHA)–ESMO #ClinicalPracticeGuideline (CPG) on HIV-associated #lymphomas. Check it now: 🔗 ow.ly/xZ8v50TcXLL

#WorldLymphomaAwarenessDay #WLAD2024 #lymphoma #lymsm Lymphoma Australia